MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Methapharm Inc

Methapharm Inc
Methapharm is a specialty pharmaceutical company whose mission is continued growth with a focus on branded niche products in the United States and/or Canada.

The company in detail

Profile

Methapharm is a specialty pharmaceutical company whose mission is continued growth with a focus on branded niche products in the United States and/or Canada. We market our own proprietary brands as well as distribute products from partner companies.

Methapharm blends corporate and entrepreneurial experiences with a common sense approach towards the optimization of business outcomes for our partners and licensors. This has led to a strong track record in the commercialization of niche brands, diagnostics, critical care, infectious disease and oncology support products.

If you are looking for a gateway to expand into Canada or the United States with your specialty product(s), Methapharm provides expertise in Sales & Marketing, Market Access, Regulatory Services and GMP Distribution Capabilities, to help partners navigate the entire process from pre-marketing authorization submission to field force deployment and follow-up. We also provide flexible arrangements for relationship and deal scenarios.

 

Out-licensing

Provocholine® (methacholine chloride) is indicated for the diagnosis of bronchial airway hyperresponsiveness in subjects suspected of having asthma. The methacholine challenge test with Provocholine® provides a measure of the severity of asthma. More

In-licensing

Methapharm has exceptional brand transfer experience across a range of niche and hospital products. More
Methapharm is looking to in-license/distribute niche/hospital brands using its exceptional brand transfer experience. More

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us